Myomo (MYO) Cash from Investing Activities (2017 - 2025)
Myomo's (MYO) quarterly Cash from Investing Activities came in at $189698.0 in Q3 2025, down 93.29% YoY from $2.8 million in Q3 2024, and up 125.05% on a QoQ basis from -$757348.0 in Q2 2025.
Myomo (MYO) Cash from Investing Activities (2017 - 2025) Analysis & Trends
Myomo (MYO) has 9 years of Cash from Investing Activities data on file, last reported at $189698.0 in Q3 2025.
- Quarterly Cash from Investing Activities fell 93.29% year-over-year to $189698.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$3.8 million (down 197.68% YoY) and the FY2024 annual result came in at $259981.0, up 112.81% from the prior year.
- Cash from Investing Activities improved to $189698.0 in Q3 2025, from -$757348.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.8 million in Q3 2024 to a low of -$3.5 million in Q1 2024.
- A 5-year average of -$256346.7 and a median of -$52793.0 in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 67882.92% in 2023, down 22831.05% in 2023.
- Tracing MYO's Cash from Investing Activities over 5 years: stood at -$23935.0 in 2021, then jumped by 85.86% to -$3385.0 in 2022, then jumped by 67882.92% to $2.3 million in 2023, then sank by 158.98% to -$1.4 million in 2024, then surged by 114.02% to $189698.0 in 2025.
- The last three Cash from Investing Activities figures came in at $189698.0 (Q3 2025), -$757348.0 (Q2 2025), and -$1.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 189,698.00 |
| Sep 30, 2025 | 189,698.00 |
| Jun 30, 2025 | -757,348.00 |
| Jun 30, 2025 | -757,348.00 |
| Mar 31, 2025 | -1.90 Mn |
| Mar 31, 2025 | -1.90 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | -1.32 Mn |
| Sep 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -2.96 Mn |
| Jun 30, 2023 | -2.96 Mn |